1Kusunoki Y, Tanaka N, Kaneko K, et al. Taerolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study [J]. Mod Rheumatol, 2009,19 (6) :616-621.
2Lee Y H, Woo J H, Choi S J, et al. Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials [J]. Scand J Rheumatol, 2010,39(4) :271-278.
3Li X, Li H, Ye H, et al. Tacrolimus therapy in adults with steroid-and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR [J]. Am J Kidney Dis, 2009, 54(1) :51-58.
4Chen W, Liu Q, Liao Y, et al. Outcomes of tacrolimus therapy in adults with refractory membranous nephmtic syndrome: a prospective, multieenter clinical trial [J]. Am J Med Sci, 2013,345 (2) :81-87.
5Yao S H, Mao J H, Xia Y H, et al. Clinical application of tacrolimus with low-dose prednisone in 21 children with steroid-resistant nephrotic syndrome [J]. Zhonghua Er Ke Za Zhi, 2011,49 ( 11 ) : 825-828.
6Mitarai T. Immunosuppressive therapies for refractory nephrotic syndrome [J]. Nihon Jinzo Gakkai Shi, 2010,52 (7):924- 927.
